The experimental results showed that in the CD8+ T cell deletion group, the Ad-CAIX/Ad-PD-L1 no longer inhibited tumor growth in mice, indicating that CD8+ T cells played a key role in anti-tumor immunity. Here, CD8A is linked to neoplasm.